Cipher Pharmaceuticals Inc
PHE
Company Profile
Business description
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
Contact
5750 Explorer Drive
Suite 404
MississaugaONL4W 0A9
CANT: +1 905 602-5840
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
43
Stocks News & Analysis
stocks
Weekly earnings wrap: FMG, WDS, COL and more
A closer look at the final major results from August reporting season.
stocks
Chart of the Week: Are US mega-cap stocks undervalued?
Opportunities emerge across US equities.
stocks
Three overpriced ASX shares without moats to avoid
These shares are trading a significant premium to our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,338.80 | 54.50 | -0.58% |
| CAC 40 | 8,462.39 | 23.19 | 0.27% |
| DAX 40 | 26,285.96 | 19.82 | 0.08% |
| Dow JONES (US) | 53,463.88 | 113.52 | -0.21% |
| FTSE 100 | 10,878.12 | 8.04 | -0.07% |
| HKSE | 25,652.97 | 141.87 | 0.56% |
| NASDAQ | 26,130.20 | 21.10 | -0.08% |
| Nikkei 225 | 66,262.16 | 405.73 | 0.62% |
| NZX 50 Index | 14,039.92 | 26.71 | 0.19% |
| S&P 500 | 7,675.70 | 1.58 | -0.02% |
| S&P/ASX 200 | 9,127.80 | 55.90 | -0.61% |
| SSE Composite Index | 3,912.52 | 23.08 | 0.59% |